Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

Per Soelberg Sorensen, Nils Koch-Henriksen, Thor Petersen, Mads Ravnborg, Annette Oturai, Finn Sellebjerg

90 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients'. Together they form a unique fingerprint.

Medicine & Life Sciences